ACI's Advanced Forum on FCPA & Anti-Corruption for the Life Sciences Industry
Event summary
Legal and compliance professionals from CROs, pharmaceutical, medical device and biotechnology companies have chosen this program to connect, compare notes and expand their networks.
Cooley partner Luke Cadigan will be presenting at the ACI's Advanced Forum on FCPA & Anti-Corruption for the Life Sciences Industry, discussing the latest compliance lessons learned from recent cases, innovative anti-corruption risk assessments, compliance best practices and defense strategies.
Featured agenda item
Former DOJ Officials Predict the Future of FCPA Investigations and Enforcement: Special Considerations for Pharmaceutical, Medical Device and Biotech Companies and CROs
Thursday, July 21, 2022: 11:00 – 11:45 am ET
Cooley partner Luke Cadigan will be a featured speaker.
During this highly anticipated session, participants will gain invaluable insights from former DOJ and SEC officials on the agencies’ enforcement postures, priorities and the evolving landscape of risk for life sciences companies.
For more information, please email Laura Miller.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.